Best practices to maximize strategic partnerships in regenerative medicine
Strategic industry partnerships are vital for biotech startups to accelerate innovation, but realizing the full potential requires grasping complex dynamics and implementing best practices for risk mitigation.
In response to an increasingly complex biopharma ecosystem, industry partnerships have become an essential strategy for start-ups. However, without an adequate understanding of the inherent complexities, strategic levers and potential landmines required to maximize the potential of these partnerships, organizations risk losing invaluable time and capital.
This webinar will explore best practices that should be adopted during the formation of such partnerships to mitigate risks, accelerate innovation, enhance competitiveness and ultimately translate scientific breakthroughs into life-changing solutions.
What will you learn?
- Why it is important to define mutual goals and objectives upfront
- Tips on establishing guidelines for data sharing and intellectual property ownership
- When to pursue and avoid complementarity of capacities and assets
- Suggestions for creating a framework for shared risk and reward
Who this may interest?
- Biotech startups
- Pre-clinical stage biotechs
Speaker
Adam Hostetler
Director of Business Operations
Cook MyoSite (PA, USA)
Adam Hostetler is responsible for Organizational Strategic Planning and the business functions of Operational Excellence, Legal and Finance at Cook Myosite. Hostetler has been with Cook MyoSite for almost 17 years, previously holding the positions of Production Manager and Material Control Manager.
This webinar was recorded on Tuesday 11 June 2024
In association with
